Section Arrow
Quote
AORT.NYSE
- Artivion
Quotes are at least 15-min delayed:2025/11/03 15:56 EST
After Hours
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 45.965
+0.595 (+1.31%)
Day High 
46.02 
Prev. Close
45.37 
1-M High
46.19 
Volume 
311.14K 
Bid
45.8
Ask
45.93
Day Low
44.2 
Open
45.43 
1-M Low
38.95 
Market Cap 
2.14B 
Currency USD 
P/E -- 
%Yield 0.17 
10-SMA 44.12 
20-SMA 42.54 
50-SMA 42.24 
52-W High 46.19 
52-W Low 21.97 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.43/0.77
Enterprise Value
2.50B
Balance Sheet
Book Value Per Share
8.90
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
388.54M
Operating Revenue Per Share
7.20
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DXCMDexCom60.03+1.81+3.11%41.08PE
After Hours -- -- --
BFLYButterfly Network2.915+0.225+8.36%-- 
After Hours -- -- --
PACBPacific Biosciences of California2.225-0.115-4.91%-- 
After Hours -- -- --
QSIQuantum-Si1.995-0.155-7.21%-- 
After Hours -- -- --
PFSAProfusa Inc0.1909-0.0483-20.19%-- 
After Hours -- -- --
Quotes are at least 15-min delayed：2025/11/03 15:56 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.